Hair metabolomics: Identification of fetal compromise provides proof of concept for biomarker discovery
Further research is warranted to explore their diagnostic and therapeutic potential in the context of disease comorbidity
- : BPC-157,
It is important to note that such violations may suggest low oral bioavailability (due to high molecular weight or excessive lipophilicity), solubility limitations (reflected in Log S and TPSA values, leading to poor dissolution), inadequate permeability, an increased risk of toxicity or adverse effects, and/or a reduced likelihood of clinical success
Therefore, this review aims to elaborate on the abnormal levels of some major metabolites, related metabolic pathways, and the latest protein acyl PTMs they mediate in tumor cells, providing new insights for diagnosis and therapy in the field of oncology
Taken together, these observations imply substantial metabolic pathways alterations in LC patients